Related Content
Download content relating to this event and topic.
Where cross-border leaders come together to define what successful ADC innovation and manufacture looks like in practice: from high-potency logistics to harmonised analytics and next-generation conjugation.

Antibody-Drug Conjugates (ADCs) are among the most complex therapeutic modalities in biopharma and the technical, analytical, regulatory, and supply chain challenges that accompany them demand specialised solutions.
ADC Manufacturing Europe 2026 is where cross-border leaders come together to define what successful ADC innovation and manufacture looks like in practice: from high-potency logistics to harmonised analytics and next-generation conjugation.

Europe is rapidly building its ADC capabilities, but fragmentation in supply chains, inconsistent analytical standards, and the gap between Asian innovation and European manufacturing continue to slow progress. ADC Manufacturing Europe 2026 addresses these challenges head-on by bringing together senior technical, supply chain, and operational leaders responsible for delivering real-world ADC programmes, not just the science on paper.
This is not a generic scientific showcase. This is where operational and technical leadership meets strategic execution:
• De-risking high-potency payload (HPAPI) and linker logistics from Asia into Europe
• Accessing next-generation bispecific ADC (bsADC) designs and novel linker chemistries through co-development and licensing pathways
• Standardising analytical assays for seamless comparability and tech transfer across continents
• Scaling robust, compliant manufacturing and stability workflows with advanced analytics and predictive tools
• Europe’s only forum dedicated to the operational and analytical realities of ADC manufacturing from procurement to GMP-ready deliverables
• Purpose-built for ADC decision-makers in Supply Chain, Conjugation Science, Analytical Development, Tech Ops, MSAT, CMC, and Quality
• Real-world case studies, interactive sessions, and benchmarking discussions that tackle fragmentation, variability, and execution risk
• Insights into multi-shore collaboration models that unlock innovation in conjugation and bispecific platforms at scale
If your role touches on getting complex ADCs from concept through conjugation into consistent, compliant manufacture, this is the room where those problems get solved.
Solving the “fragmentation fracture” in ADC supply chains by de-risking the movement of high-potency payloads and linker chemistries from Asian suppliers into European manufacturing environments.
Exploring access to Asian innovation in bispecific ADCs (bsADCs) and cutting-edge linker technologies, and shifting from traditional outsourcing toward co-development and licensing frameworks that accelerate pipeline progress.
Standardising critical analytical assays (e.g., DAR, free payload quantitation, stability) to enable seamless technology transfer and product comparability between European development labs and Asian contract manufacturing partners.
Practical frameworks and tools for scaling ADC production and ensuring product quality:
View the Key Themes for
ADC Manufacturing Europe 2026
Register today to secure your ticket.
Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders.
Join the roster of esteemed colleagues to discuss what you or your company are bringing to the biopharmaceutical industry.
Apply to SpeakSelect the relevant ticket for your organisation.
*Delegate tickets must be purchased under the correct classification.
Biopharma tickets are strictly reserved for professionals employed by pharmaceutical or biopharmaceutical companies that develop, own, or commercialise therapeutic drug products, including organisations with an internal drug pipeline spanning discovery, development, clinical, or commercial stages. This category applies to companies whose primary business is the development or manufacture of drug products, not the provision of enabling technologies, equipment, platforms, or services.
Service, Solution, and Technology Provider tickets apply to all organisations offering services, platforms, technologies, equipment, consultancy, manufacturing services, or commercial solutions to the pharma and biopharma industry. This includes, but is not limited to, CROs, CDMOs, technology and equipment vendors, consultants, suppliers, and solution providers, regardless of scientific or technical focus.
Important Notice
All registrations are reviewed to ensure correct classification. Purchasing an incorrect ticket does not guarantee entry to the event. IMAPAC retains full discretion to deny access, reclassify registrations, and issue an invoice for the price difference required for correct attendance. Incorrect ticket purchases made under an inappropriate classification are not eligible for refunds under any circumstances, including where the registrant chooses not to upgrade or attend.
Be the first in line!
Register your interest to get access to tickets as soon as they go live.
Contact the IMAPAC to learn about our sponsorship process, rates and more.
Visit the event page to view more content.
Download content relating to this event and topic.
Visit the event page to view more content.
Visit the awards page to view more content.
To stay informed about event updates, including date, venue, and agenda, please subscribe to our our official social media channels for real-time updates and announcements.
The conference will provide a comprehensive learning experience covering various aspects of the dynamic biopharmaceutical industry, ensuring attendees gain valuable insights and knowledge.
We are committed to ensuring the safety and well-being of all attendees. We will implement rigorous safety measures in line with local health guidelines and regulations. Specific safety measures will be communicated closer to the event date to ensure they align with the most up-to-date health recommendations. Rest assured, your safety is our priority.
We welcome presentation submissions. If you’re interested in speaking at the event, please visit this page on our website for submission guidelines and deadlines.
Our event is designed to cater to a wide range of professionals within the biopharmaceutical industry, including researchers, scientists, executives, regulatory experts, and professionals involved in drug development and manufacturing.
Participants can expect to gain insights from industry experts, network with peers, and stay up-to-date with the latest trends and innovations in biopharmaceuticals
Yes, we have networking sessions, workshops, and social events scheduled throughout the event to facilitate connections and collaborations among attendees.
Yes, we offer sponsorship and exhibition opportunities for businesses and organizations. Please visit our this page on our website for more information.
To register for the event, you'll find multiple "register" buttons on this page to get started. You’ll find detailed instructions and options for registration, including pricing and deadlines.
Don't miss out on unique networking, speaking and sponsorship opportunities.